Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptation
- 1 January 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (2) , 339-348
- https://doi.org/10.1016/0006-2952(93)90069-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line: Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferaseBiochemical Pharmacology, 1991
- Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sitesNucleic Acids Research, 1991
- Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivoCancer Chemotherapy and Pharmacology, 1988
- Recent studies of DNA topoisomerasesBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1987
- Comparison of three actin-coding sequences in the mouse; Evolutionary relationships between the actin genes of warm-blooded vertebratesJournal of Molecular Evolution, 1986
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985
- DNA topoisomerase I from calf thymus is inhibited in vitro by poly(ADP‐ribosylation)European Journal of Biochemistry, 1983
- Effects of camptothecin on RNA synthesis in leukemia L1210 cellsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1971
- Camptothecin inhibits macromolecular synthesis in mammalian cells but not in isolated mitochondria or lE. coliBiochemical and Biophysical Research Communications, 1970
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966